glp-1 news today october 2025 Agonists Market Report 2025-2033, By Product, Molecule, and Geo Regulating a "Miracle Drug": GLP-1
Description
The positive impact of GLP-1RA therapy on lipids is an important contributor to these outcomes.
Retatrutide vs Semaglutide: Evidence-based comparison of the investigational triple GIP/GLP-1/glucagon agonist versus the FDA-approved GLP-1 agonist
The injectable GLP-1 market is a 1,000 crore opportunity in India today
3. Personalised Treatment Plan
Alarmingly, this trend is growing and increasingly affecting younger populations at an accelerating rate [2]
